Arisan Therapeutics Inc
CAGE Code: 616D2
NCAGE Code: 616D2
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 962535782
Summary
Arisan Therapeutics Inc is an Active Commercial Supplier with the Cage Code 616D2 and is tracked by Dun & Bradstreet under DUNS Number 962535782..
Address
5825 Avenida Encinas
Carlsbad CA 92008-4401
United States
Points of Contact
No Points of Contact...
Related Information
People who viewed this 'CAGE Code' also viewed...
Allenbach Industries Inc Cadtronics Associates Daly, Veronica Joy Intl Religious Supplies J H H Welding Advanced Risk Control Technologies Byrnes Co Asap Solutions Inc Ortegas Canvas And Sail Solsource Computer Jm Digtialworks Kelley Graphics North County Blueprint Co Inc Baron Center Inc. Vince Dixon Ford, Inc Sharons Restaurant Equipment And Environmental Management Consortium Salient Networks, Inc. Chilton Marketing Co Job Site Rentals Llc
Frequently Asked Questions (FAQ) for CAGE 616D2
- What is CAGE Code 616D2?
- 616D2 is the unique identifier used by NATO Organizations to reference the physical entity known as Arisan Therapeutics Inc located at 5825 Avenida Encinas, Carlsbad CA 92008-4401, United States.
- Who is CAGE Code 616D2?
- 616D2 refers to Arisan Therapeutics Inc located at 5825 Avenida Encinas, Carlsbad CA 92008-4401, United States.
- Where is CAGE Code 616D2 Located?
- CAGE Code 616D2 is located in Carlsbad, CA, USA.
Contracting History for CAGE 616D2 Most Recent 25 Records
- 75N93023C00051
- To Conduct Non-Clinical Good Laboratory Practice (Glp) In Vivo Genotoxicity And Reproductive Toxicology And Glp Development And Reproductive (Dart) Toxicology Studies.
- 18 Sep 2023
- To Conduct Non-Clinical Good Laboratory Practice (Glp) In Vivo Genotoxicity And Reproductive Toxicology And Glp Development And Reproductive (Dart) Toxicology Studies.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $3,692,037.00
- Department Of Health And Human Services (Hhs)
- W911SR21C5001
- Phase Ii Base Period
- 23 Aug 2023
- Phase Ii Base Period
- W6qk Acc-Apg
- Department Of Defense (Dod)
- $526,793.52
- Department Of Defense (Dod)
- W911SR21C5001
- Sbir Phase Ii For Research On Efficacy Of Arn-75039 Against Lassa Virus.
- 20 May 2022
- Sbir Phase Ii For Research On Efficacy Of Arn-75039 Against Lassa Virus.
- W6qk Acc-Apg
- Department Of Defense (Dod)
- $269,361.72
- Department Of Defense (Dod)
- W911SR21C5001
- Phase Ii Base Period
- 25 Sep 2021
- Phase Ii Base Period
- W6qk Acc-Apg
- Department Of Defense (Dod)
- $269,361.72
- Department Of Defense (Dod)
- W911SR21C5049
- Phase Ii - Sbir Topic Cbd192-006
- 30 Sep 2021
- Phase Ii - Sbir Topic Cbd192-006
- W6qk Acc-Apg
- Department Of Defense (Dod)
- $587,720.40
- Department Of Defense (Dod)
- W911SR21C5049
- Phase Ii - Base Period
- 31 May 2022
- Phase Ii - Base Period
- W6qk Acc-Apg
- Department Of Defense (Dod)
- $1,099,662.12
- Department Of Defense (Dod)
- W911SR21C5049
- Phase Ii - Base Period
- 26 Jul 2022
- Phase Ii - Base Period
- W6qk Acc-Apg
- Department Of Defense (Dod)
- $1,099,662.12
- Department Of Defense (Dod)
- W911SR21C5049
- Extension Of Period Of Performance
- 28 Jul 2023
- Extension Of Period Of Performance
- W6qk Acc-Apg
- Department Of Defense (Dod)
- $1,099,662.12
- Department Of Defense (Dod)
- W911QY20P0080
- Principal Investigator
- 15 Apr 2020
- Principal Investigator
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $96,111.02
- Department Of Defense (Dod)
- W911QY20P0069
- Pk And Tolerability Study
- 3 Feb 2020
- Pk And Tolerability Study
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $167,441.80
- Department Of Defense (Dod)
- W911QY20P0069
- Pk And Tolerability Study
- 9 Sep 2020
- Pk And Tolerability Study
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $167,441.80
- Department Of Defense (Dod)
- W911QY20P0080
- Principal Investigator
- 7 Feb 2020
- Principal Investigator
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $96,111.02
- Department Of Defense (Dod)
- W911QY20P0069
- Pk And Tolerability Study
- 16 Apr 2020
- Pk And Tolerability Study
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $167,441.80
- Department Of Defense (Dod)
- W911QY20P0080
- Principal Investigator
- 23 Apr 2020
- Principal Investigator
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $96,111.02
- Department Of Defense (Dod)